News

BlogsPosts
As Seen In
Chief Scientist Dr. Kevin McElwee Interviewed In Barcelona Article at Eldiariomontanes.es
  (English Translation) Injected hair stem cells are emerging as the most effective therapy against baldness

BlogsPosts
As Seen In
Chief Scientist Dr. Kevin McElwee Interviewed In Barcelona Article at Hazteoir.org
(English Translation) HAZTEOIR.ORG 
The website of the active citizen June 22, 2012
BlogsPosts
Press Release
RepliCels Chief Scientific Officer Updates European Hair Research Society on RepliCels TS001-2009 First-in-man Clinical Trial
VANCOUVER, BC – June 26, 2012 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)
BlogsPosts
Press Release
Further Analysis Reveals Double Digit Hair Growth in RepliCels First-in-man Clinical Trial
Company Takes Next Steps for Phase IIb Dosing Trial
BlogsPosts
Press Release
RepliCel Releases Positive Results from the Interim Analysis of Data from its First-in-man TS001-2009 Clinical Trial
VANCOUVER, BC – May 2, 2012 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)
BlogsPosts
As Seen In
Ask Men features an interview with RepliCel Life Sciences CEO David Hall
  AskMen.com Men And Balding By Jeremy Berger, February 6, 2012 The plague that has dogged us for
BlogsPosts
As Seen In
September 11th Episode of The Bald Truth featuring RepliCel Life Sciences
To watch the September 11th episode of The Bald Truth, click here: http://www.youtube.com/watch?v=N8yO96ANRYc
Previous 1 .. 8 9 10 11 12

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.